Iterum Therapeutics
(ITRM) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
1.96
2.35%
After-hours Jan 03, 2025, 05:40 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Revenue | n/a | n/a | n/a | n/a | 37.00K | 869.00K | 508.00K | n/a |
Cost of Revenue | 1.75M | 1.80M | 2.10M | 161.00K | n/a | n/a | n/a | n/a |
Gross Profit | -1.75M | -1.80M | -2.10M | -161.00K | 37.00K | 869.00K | 508.00K | n/a |
Operating Income | -47.47M | -30.38M | -24.54M | -32.13M | -102.02M | -76.56M | -29.45M | -13.36M |
Interest Income | 1.43M | 2.36K | 4.53K | 12.30K | 861.00 | n/a | 277.00K | n/a |
Pretax Income | -37.76M | -44.13M | -90.86M | -51.26M | -102.69M | -76.58M | -28.96M | -13.35M |
Net Income | -38.37M | -44.43M | -91.56M | -52.01M | -103.13M | -77.06M | -29.41M | -13.46M |
Selling & General & Admin | 7.48M | 12.77M | 13.82M | 11.05M | 11.28M | 8.78M | 4.46M | 3.26M |
Research & Development | 38.24M | 17.62M | 10.71M | 21.07M | 90.77M | 68.65M | 25.50M | 10.10M |
Other Expenses | n/a | -16.85M | 195.00K | 213.00K | 196.00K | 401.00K | 216.00K | 8.00K |
Operating Expenses | 47.47M | 30.38M | 24.54M | 32.13M | 102.06M | 77.43M | 29.96M | 13.36M |
Interest Expense | n/a | 2.36M | 5.55M | 15.10M | 861.00K | 426.00K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 47.47M | 30.38M | 24.54M | 32.13M | 102.06M | 77.43M | 29.96M | 13.36M |
Income Tax | 613.00K | 301.00K | 705.00K | 743.00K | 444.00K | 472.00K | 444.00K | 113.00K |
Shares Outstanding (Basic) | 12.96M | 12.24M | 163.37M | 24.01M | 14.52M | 582.27K | 506.28K | 506.28K |
Shares Outstanding (Diluted) | 12.96M | 12.24M | 163.37M | 24.01M | 14.52M | 582.27K | 506.28K | 506.28K |
EPS (Basic) | -2.96 | -3.63 | -0.56 | -2.17 | -7.1 | -132.34 | -58.08 | -26.59 |
EPS (Diluted) | -2.96 | -3.63 | -0.56 | -2.17 | -7.1 | -132.34 | -58.08 | -26.59 |
EBITDA | -34.58M | -39.97M | -83.20M | -36.01M | -101.67M | -76.02M | -29.39M | -13.35M |
Depreciation & Amortization | 1.75M | 1.80M | 2.10M | 161.00K | 152.00K | 136.00K | 65.00K | 13.36M |